The time of day you exercise could be key in slashing the risk of arthritis
Exercising at certain times of day helps to keep the body's clocks in sync and so could slow the progression of arthritis, according to an expert. (Source: Daily Express - Health)
Source: Daily Express - Health - November 16, 2023 Category: Consumer Health News Source Type: news
Novel Gout Drug Aces Mid-Stage Tests
(MedPage Today) -- SAN DIEGO -- An investigational once-daily oral agent that inhibits urate transporter-1 (URAT1) as a means of forcing uric acid excretion showed good efficacy and safety in a pair of phase II trials reported here.
In one of... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 16, 2023 Category: Rheumatology Source Type: news
First Referral Guide Issued for Axial Spondyloarthritis First Referral Guide Issued for Axial Spondyloarthritis
The draft recommendations are a ' good first step, ' but more awareness around axial spondyloarthritis in the non-rheumatology community is also needed to improve diagnosis, one expert said.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Uh-Oh, Is a Robot Coming for Your Radiographic Analysis Job?
(MedPage Today) -- SAN DIEGO -- Joint space narrowing (JSN) and erosions in rheumatoid arthritis (RA) were measured and graded about as well by computerized x-ray analysis as by a human rheumatologist, a researcher reported here.
With the live... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - November 15, 2023 Category: Radiology Source Type: news
CAR T-Cell Approach to Autoimmune Disease Gains Traction
(MedPage Today) -- SAN DIEGO -- Chimeric antigen receptor (CAR) T-cell therapy increasingly looks like the next big thing in autoimmune rheumatic disease (ARD) therapy, with new reports here continuing to demonstrate positive results, and with... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 15, 2023 Category: Rheumatology Source Type: news
Apremilast Beats Placebo in Early PsA Affecting Few Joints Apremilast Beats Placebo in Early PsA Affecting Few Joints
Oligoarticular PsA can significantly affect quality of life even though few joints are affected, and there ' s a lack of relevant clinical data to guide treatment.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Vasculitis Gives Higher Risk for Adverse Pregnancy Outcomes Vasculitis Gives Higher Risk for Adverse Pregnancy Outcomes
This study should help inform our family planning conversations with our vasculitis patients," Lindsay S. Lally, MD, said.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
When to Order Antinuclear Antibodies in Primary Care When to Order Antinuclear Antibodies in Primary Care
Tips from an expert rheumatologist also reveal when not to order ANA and how to interpret the results.The Curbsiders (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 14, 2023 Category: Internal Medicine Tags: Internal Medicine Commentary Source Type: news
Novel IL-17A Blocker Continues to Impress in PsA
(MedPage Today) -- SAN DIEGO -- The triple-action investigational agent known as izokibep was highly effective against psoriatic arthritis (PsA) over 46 weeks in a new analysis of the product's first phase II trial, a researcher said here.
Following... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 14, 2023 Category: Rheumatology Source Type: news
TNF Inhibitors May Be OK for Treating RA-ILD TNF Inhibitors May Be OK for Treating RA-ILD
Efficacy, safety findings for the use of TNF inhibitors vs other biologic disease-modifying antirheumatic drugs in treating RA-ILD contrast with those of some smaller observational studies.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 14, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Aclaris halts work on its experimental rheumatoid arthritis drug after clinical trial failure
Aclaris will discontinue further development of the drug candidate, including halting enrollment of its ongoing phase 2 trial targeting psoriatic arthritis. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 14, 2023 Category: Pharmaceuticals Authors: John George Source Type: news
Male, Female Veterans Have Increased Prevalence of Arthritis
TUESDAY, Nov. 14, 2023 -- Male and female veterans have a higher prevalence of arthritis than nonveterans, according to research published in the Nov. 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2023 Category: Pharmaceuticals Source Type: news
New Approaches Show Promise in Helping People With Lower-Back Pain
Often there is no clearly identifiable physical cause for low-back pain, leaving patients to veer from one ineffective treatment to another. Millions of adults struggle for years with chronic low-back pain—a disabling ailment that has no easy fix. Common causes include injury, arthritis and… (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2023 Category: Consumer Health News Source Type: news
Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Disease
(MedPage Today) -- SAN DIEGO -- Rates of certain infections and other adverse effects were substantially higher in patients receiving sodium-glucose cotransporter-2 (SGLT-2) inhibitors when they also had rheumatoid arthritis or other systemic... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 14, 2023 Category: Cardiology Source Type: news
CPPD Nomenclature Is Sore Subject for Gout Group CPPD Nomenclature Is Sore Subject for Gout Group
Since 2011, the nomenclature guidelines have been cited hundreds of times, but a new report finds that the medical literature mostly hasn ’t followed the recommendations.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 14, 2023 Category: Gastroenterology Tags: Rheumatology News Source Type: news
